KEMOTEX BIO OÜ

Media page and news feed
?
This company's branding has already reached 1,450 peopleand his is followed by 31 Storybook users.On average, the company has been rated 4.3 points.but there is

KEMOTEX BIO OÜ current status

This company's branding has already reached 1,450 peopleand his is followed by 31 Storybook users.On average, the company has been rated 4.3 points.but there is no comment.

Strategic decision: No desire to increase customer base
Board member Riivo Sinijärv (13.02.2025): "We focus only on providing high-quality service to existing customers and maintaining relationships. We do not plan to increase our customer base."

Tegevusaruanne 2023

Kemotex Bio OÜ on Eestis registreeritud ja Eestis tegutsev ettevõte aastast 1990, kelle tegevusaladeks on hambaravimaterjalide maaletoomine ja müümine ning biopreparaatide tootmine.

2023. aastal Kemotex Bio OÜ importis ja müüs hambaravis kasutatavaid materjale ning tootis ja eksportis biokeemia tooteid.

Kemotex Bio OÜ müügitulu 2023. aastal oli 225025 (2022.aastal 257061) eurot. Aruandeaasta tulemiks kujunes 3320 (2022.aastal 4529) eurot. Müügitulu vähenes seoses Saksa sünteeside lõppemisega, kuna alltöövõtjad on tegevuse lõpetanud ning uut alltöövõtjat ei ole töö spetsiifilisuse tõttu olnud võimalik leida.

Hambaravitarvete puhul on tegevuse põhisuunaks sortimendi mitmekesistamine, klientidele kvaliteetse teeninduse tagamine ning üldise hea hinna/kvaliteedi suhte säilitamine.

Kemotex Bio OÜ majandustegevus jätkub 2024. aastal samades tegevussuundades.

Comments (0)


Are you sure you want to delete this article?

Dropdown

all articles

Are you sure you want to delete this article?

Loader

Loader

App Ad

Scorestorybook Chrome extension

The Storybook extension tells you which company's website you are currently on and how reliable that company is today. download extension

See the background of the caller! Storybook App brings you direct contacts for 400,000 Estonian companies and individuals (managers, officials). The data is enriched with solvency and financial information.